Medicine for curing ovulation failure and preparing method thereof
A drug and barrier technology, which is applied in the field of drugs for the treatment of ovulation disorders and its preparation, can solve the problems of inconspicuous therapeutic effects, weak pertinence, and few varieties, and achieve the effect of no toxic side effects, obvious curative effect, and strong pertinence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Embodiment 1, have the preparation of the Chinese medicine compound preparation (medicine for treating ovulation disorder) for treating ovulation disorder
[0049] The present embodiment provides Chinese medicine compound preparation A and Chinese medicine compound preparation B for treating ovulation disorder. , peach kernel and angelica are (10-25): (6-15): (6-15): (10-20): (9-20): (10-20): (9-20 ): (5-15): (3-15): (9-20) is prepared by traditional Chinese medicine preparation equipment, Chinese medicine compound preparation B is composed of maca, epimedium, psoralen, sealwort, yam and rehmannia glutinosa according to the quality The ratio of parts is (10-25):(6-15):(6-15):(10-20):(9-20):(10-20) and is prepared by traditional Chinese medicine preparation equipment. Among them, maca, epimedium, psoraleae, sealwort, yam, rehmannia glutinosa, fritillaria, saponins, peach kernels, and angelica are all single-flavored Chinese medicine granules prepared from corresponding ...
Embodiment 2
[0063] Embodiment 2, Chinese medicine compound preparation A and Chinese medicine compound preparation B can be used to treat ovulation disorder
[0064] 1. Treatment of Ovulation Disorders by Chinese Medicine Compound Preparation A
[0065] 1. Research object
[0066] Among 528 female patients with ovulatory disorders (experimental group 1), 219 cases belonged to WHO type Ⅱ patients, and 309 cases were elderly patients (greater than 35 years old).
[0067] Among the 528 patients with ovulatory disorders, there were 118 cases aged 21-25, who were randomly divided into four groups, namely group A1 (29 cases), group A2 (30 cases), group A3 (29 cases) and group A3 (29 cases). 4 groups (30 cases);
[0068] A total of 113 cases aged 26-30 were randomly divided into four groups, namely Group B 1 (29 cases), Group B 2 (28 cases), Group B 3 (28 cases) and Group B 3 (28 cases). 4 groups (28 cases);
[0069] A total of 106 cases aged 31-35 were randomly divided into four groups, nam...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com